Skip to Content

Rotation & Research Requirements

Surgical Oncology Rotation (Director, Dr. Steven Curley)

Each fellow will have a consecutive two month rotation on the Surgical Oncology Service. Each candidate will be with Steven Curley, M.D., the Surgical Oncology Fellowship director, several weeks before the rotation begins to determine which two services are optimal for the candidate. There are currently six GI tumor, four breast, four melanoma/sarcoma and one endocrine subservices within Surgical Oncology.

Radiation Oncology Rotation (Director: Dr. Thomas Buchholz)

The candidate’s rotation in the Department of Radiation Oncology will consist of a clinical eight-week experience (50% time). The rotation will be divided to allow experiences with two disease-site services. The selection of these disease-site services will be determined by the candidate and the Department of Radiation Oncology program liaisons (Thomas A. Buchholz, M.D., Professor, Radiation Oncology, George Thomas, Director of Research and Education, Radiation Oncology). Disease-sites will be selected according to the candidate’s areas of research interest and areas in which the best educational opportunities exist.

Pediatrics Rotation (Directors, Drs. Eugenie S. Kleinerman and Laura Worth)

The TRIUMPH post-doc will pair up with one of the Pediatric Oncology first-year fellows. Mondays will start at 9 a.m. with patient report. The TRIUMPH postdoc would go to the clinic with the first-year fellow (one month on leukemia and the second month on the solid tumor service). Noon Pediatric Grand Rounds, then afternoon clinic until 3 p.m., when he/she would attend the neuro-oncology protocol planning meeting, at 4 p.m. the leukemia/lymphoma patient care, protocol planning meeting and then 5 p.m. at the core curriculum for all of the Anderson fellows.

Medical Oncology Rotation (Director, Dr. Bob Wolff)

Each fellow will participate in a Medical Oncology rotation for two consecutive months. Each fellow is required to meet with either Dr. Wolff or Trent several weeks before the rotation begins to determine which Medical Oncology department is best suited for the individual.

Investigational Cancer Therapeutics (Director, Dr. David Hong)

The candidate’s rotation in the Department of Investigational Cancer Therapeutics (ICT) will consist of a clinical eight-week experience. The purpose of the rotation is to provide the candidate an introduction to early cancer drug development. The candidate will be paired with one of the current ICT fellows and directed mentorship by a clinical faculty member. Candidates with a long-term interest in cancer drug development are encouraged to extend the period of time spent within the Department of Investigational Cancer Therapeutics which may involve data analysis and learning to write protocols.

Clinical Pharmacy Translational Research Experiential Rotation (Director, Dr. Judith Smith)

The goal of this clinical pharmacy translational research experiential rotation is to provide cross-training in clinical pharmacy practice and pharmacology laboratory studies enabling the fellow, at the conclusion of training, to follow either an academic or industrial professional translational research track.  The fellow will gain extensive experience in clinical pharmacy practice, teaching, pre-clinical and clinical study design; pharmacokinetic/pharmacodynamic modeling; data management and analysis; computer-based molecular modeling; and presentation and publication of scientific data.  While the focus of the fellowship is the clinical pharmacology of new anticancer drugs the sills developed in the fellowship are applicable to development of any pharmaceutical class.

Research Requirements

Postdocs will be assigned to a basic/translational laboratory upon being accepted to the program. During the first year, they will spend 50% of their time in the laboratory and the other 50% spent taking the required didactic courses as they are offered, attend the Institutional Grand Round Seminar Series, and complete three of the five rotations. At the end of their first year, they will be paired up with a senior physician scientist as their clinical mentor, who, together with the basic science/translational mentor, will design a research project. During the second year, the postdocs will spend 80% of their time in research and 20% taking the remaining two rotations and any other course work that needs to be completed. At the beginning of their first year, the postdocs need to form a mentoring committee composed of the postdoc's basic research mentor and the organizers of the TRIUMPH Program and the rotation leaders who will assist the postdoc in directing his or her research.


© 2014 The University of Texas MD Anderson Cancer Center